Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination
2017
Consider rituximab as a possible treatment for combined central and peripheral demyelination.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
2
Citations
NaN
KQI